Colin Traynor
Foot & Ankle Surgery · San Francisco, CANPI 1821361700
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. KCI USA, Inc. accounts for 93.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $45,305 and has fallen 97.9% since, to $951 in 2025. Among foot & ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $409.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$70K
- Solventum Corporation$2K
- Inari Medical, Inc.$1K
- Smith+Nephew$813
- Paragon 28, Inc.$536
- Integra Lifesciences Corporation$243
- plus $682 from 10 others
What the payments were for
- Consulting fees$13,22518%
- Speaking & faculty fees$38,71951%
- Travel & lodging$18,39924%
- Food & beverage$4,3806%
- Education$5501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 103 | $70,120 |
| Solventum Corporation | 7 | $1,716 |
| Inari Medical, Inc. | 4 | $1,162 |
| Smith+Nephew | 31 | $813 |
| Paragon 28, Inc. | 9 | $536 |
| Integra Lifesciences Corporation | 9 | $243 |
| Stryker | 1 | $154 |
| Osiris Therapeutics Inc. | 8 | $120 |
| Kerecis Limited | 4 | $119 |
| Johnson & Johnson | 1 | $86 |
| Organogenesis Inc. | 2 | $76 |
| Evolution Surgical, Inc | 1 | $38 |
| Bone Support Inc. | 1 | $27 |
| Polarityte, Inc. | 1 | $26 |
| Acera Surgical, Inc. | 1 | $19 |
| Avita Medical Americas, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SNAP$54,820
- ACTIV.A.C.$6,450
- VAC VERAFLO$4,990
- ACTIVAC$4,872
- V.A.C. VERAFLO$4,338
- 3M Coban$3,163
- V.A.C. DERMATAC$3,163
- PREVENA$3,044
- PROMOGRAN PRISMA$2,263
- ADAPTIC$1,500
- PREVENA RESTOR ARTHROFORM$1,175
- PREVENA RESTOR BELLAFORM$1,175
- Bair Hugger$1,100
- V.A.C. VERAFLO CLEANSE CHOICE$1,100
- FLOWTRIEVER CATHETER, S$1,064
- CT THROMBECTOMY SYSTEM KIT$1,064
- ABTHERA$620
- DERMATAC$550
- 3M Cavilon$450
- SpotOn$300
How this compares
$75,273 in reported general payments places this provider in the 95th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 15 | $297 |
| Clotrimazole | 17 | $217 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in San Francisco
- Michael CoughlinSan Francisco$1.6M
- Tracey VlahovicSan Francisco$313K
- Charles ParksSan Francisco$225K
- John SchuberthSan Francisco$216K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.